ANN ARBOR – NanoBio Corporation Tuesday announced that George Arida, managing director at Venture Investors LLC, has been appointed to the Company’s Board of Directors. Venture Investors is an investment firm that provides funding to healthcare and technology companies in the Midwest.
Arida has a proven track record of identifying emerging healthcare companies and guiding growth initiatives, business strategy, and financial decisions to help create exciting exit opportunities. He joined Venture Investors in 2000 and was appointed Managing Director of Venture Investors Early Stage Fund IV in 2006. Prior to joining Venture Investors, Arida was the CFO of a financial consulting and brokerage firm.
?George is intimately familiar with the dynamics of clinical-stage biopharmaceutical companies. His understanding of both business strategy and scientific innovation enables him to provide guidance that simultaneously drives both aspects of a company,? said James R. Baker, MD, CEO and founder of NanoBio. ?George led Venture Investors? 2009 investment in NanoBio, so he is already strategically involved with the company. His experience and knowledge can now be further leveraged through his seat on our Board, as we look ahead to the exciting future of NanoBio and continue to evaluate various partnerships and financing options.?
Arida served as Chairman of the Board of Directors of Nerites, Inc. through the January 2011 acquisition by Kensey Nash and served as Chairman of Zystor Therapeutics, Inc. He currently serves as Chairman of the Board of Directors of Celleration, Inc. He also serves on the Board of Directors for Chromatin, Inc., ProCertus BioPharm, Inc., and the Mid-America Healthcare Investors Network.
Arida holds a Bachelor of Science degree in Chemical Engineering from the University of Illinois at Urbana-Champaign and a Master of Business Administration degree with high honors from the University of Chicago.
a>>
